The iQ Group Global

George J is the CEO of The iQ Group Global. To contact George J email at [email protected].

The decision makers in The iQ Group Global are Con Tsigounis, Lynne Johnson, etc. Click to Find The iQ Group Global decision makers emails.

The iQ Group Global provides a wide range of services including Medical Affairs, Venture Capital, Contract Pharmaceutical Sales, Marketing & Commercialisation Services, and Structured Financial Products. We specialize in transforming bioscience discoveries into market-ready medical innovations through comprehensive support in areas such as biotech IP asset management, fund management, investment banking, clinical research, and regulatory strategy.

We support biotech startups through our venture capital services, which include funding opportunities and strategic guidance. Our team of experts works closely with startups to navigate the complexities of bringing a product to market, from initial research and development to regulatory approvals and commercialization strategies. We also offer access to our extensive network of industry contacts to facilitate partnerships and collaborations.

The iQ Group Global operates primarily within the life sciences sector, focusing on biotechnology, pharmaceuticals, and medical devices. Our expertise extends to various related fields, including clinical research, regulatory affairs, and investment banking, allowing us to provide comprehensive support across the entire lifecycle of medical innovations.

Yes, The iQ Group Global offers specialized services in regulatory and reimbursement strategy. Our team is well-versed in the complexities of regulatory requirements and reimbursement processes across different markets. We help clients navigate these challenges to ensure their products meet necessary regulations and secure appropriate reimbursement pathways, ultimately facilitating successful market entry.

The iQ Series 8 is a structured fund management initiative by The iQ Group Global designed to invest in promising bioscience innovations. This fund focuses on identifying and supporting high-potential projects in the life sciences sector, providing them with the necessary capital and resources to advance their development. Investors benefit from our expertise in managing biotech assets and navigating the complexities of the investment landscape.

To explore partnership opportunities with The iQ Group Global, you can visit our website at http://theiqgroupglobal.com and navigate to the 'Contact Us' section. There, you will find our contact information and a form to submit your inquiry. Our team is eager to discuss potential collaborations and how we can work together to advance bioscience innovations.